The study further demonstrated that histamine-producing L. reuteri can suppress tumorigenesis in an established CRC mouse model but compared to H1R antagonists, H2R antagonists dramatically increased both the size and number of tumors (Shi et al., 2019). The gene discussed is HRH2; the disease is colorectal carcinoma.